EUVIMEDEUVIMED entdecken
Open Access

Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission

Paula-Josefina Gomez-Gonzalez iD, Antima Gupta iD, Laura G Drought, Avnish Patel iD, John Okombo iD, Mariëtte van der Watt iD, Ryan Walker-Gray, Kyra A Schindler iD, Anna Y Burkhard, Tomas Yeo iD, Sunil K Narwal iD, Talia S Bloxham iD und 35 weitere

Science Advances · 06.12.2024 · 10 (49)

DOI: 10.1126/sciadv.adq1383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.12.2024. Verfasst von Paula-Josefina Gomez-Gonzalez und 46 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. Hauptthemen laut MEDLINE: Plasmodium falciparum, Phosphodiesterase Inhibitors, Antimalarials. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Gates Foundation, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclic nucleotide–dependent phosphodiesterases (PDEs) play essential roles in regulating the malaria parasite life cycle, suggesting that they may be promising antimalarial drug targets. PDE inhibitors are used safely to treat a range of noninfectious human disorders. Here, we report three subseries of fast-acting and potent Plasmodium falciparum PDEβ inhibitors that block asexual blood-stage parasite development and that are also active against human clinical isolates. Two of the inhibitor subseries also have potent transmission-blocking activity by targeting PDEs expressed during sexual parasite development. In vitro drug selection experiments generated parasites with moderately reduced susceptibility to the inhibitors. Whole-genome sequencing of these parasites detected no mutations in PDEβ but rather mutations in downstream effectors: either the catalytic or regulatory subunits of cyclic adenosine monophosphate–dependent protein kinase (PKA) or in the 3-phosphoinositide-dependent protein kinase that is required for PKA activation. Several properties of these P. falciparum PDE inhibitor series make them attractive for further progression through the antimalarial drug discovery pipeline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumPhosphodiesterase InhibitorsAntimalarialsAnimalsHumansCulicidaeMalaria, FalciparumLife Cycle StagesCyclic AMP-Dependent Protein KinasesProtozoan ProteinsPhosphoric Diester Hydrolases3',5'-Cyclic-AMP Phosphodiesterases

Substanzen

Phosphodiesterase InhibitorsAntimalarialsCyclic AMP-Dependent Protein KinasesProtozoan ProteinsPhosphoric Diester Hydrolases3',5'-Cyclic-AMP Phosphodiesterases

Autor:innen und Institutionen

  • Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.
  • Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York, NY, USA.
  • Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria, South Africa.
  • Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Institute for Sustainable Malaria Control, University of Pretoria, Pretoria, South Africa.

ORCID-Profile: Paula-Josefina Gomez-Gonzalez, Antima Gupta, Avnish Patel, John Okombo, Mariëtte van der Watt, Kyra A Schindler, Tomas Yeo, Sunil K Narwal, Talia S Bloxham, Janette Reader, Heekuk Park, Lindsay B Stewart, Mojca Kristan, Youri M van Nuland, Emilia Manko, Donelly A van Schalkwyk, Yang Zheng, Rob Leurs, Koen J Dechering, Anna Caroline C Aguiar, Rafael V C Guido, Dhelio B Pereira, Philip J Rosenthal, Jeremy N Burrows, Anne-Catrin Uhlemann, Lyn-Marié Birkholtz, Jennifer L Small-Saunders, David A Fidock, Mark Gardner, David A Baker

Förderung

  • NIAID NIH HHS
  • Gates Foundation
  • Wellcome Trust

Zitieren

APA

Gomez-Gonzalez, P. J., Gupta, A., Drought, L. G., Patel, A., Okombo, J., van der Watt, M., Walker-Gray, R., Schindler, K. A., Burkhard, A. Y., Yeo, T., Narwal, S. K., Bloxham, T. S., Flueck, C., Walker, E. M., Rey, J. A., Fairhurst, K. J., Reader, J., Park, H., Pollard, H. G., …, & Baker, D. A. (2024). Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission. Science Advances, 10(49). https://doi.org/10.1126/sciadv.adq1383

Vancouver

Gomez-Gonzalez PJ, Gupta A, Drought LG, Patel A, Okombo J, van der Watt M, et al. Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission. Science Advances. 2024;10(49). doi:10.1126/sciadv.adq1383

BibTeX
@article{GomezGonzalez2024,
  author = {Gomez-Gonzalez, Paula-Josefina and Gupta, Antima and Drought, Laura G and Patel, Avnish and Okombo, John and van der Watt, Mariëtte and Walker-Gray, Ryan and Schindler, Kyra A and Burkhard, Anna Y and Yeo, Tomas and Narwal, Sunil K and Bloxham, Talia S and Flueck, Christian and Walker, Eloise M and Rey, Joshua A and Fairhurst, Kate J and Reader, Janette and Park, Heekuk and Pollard, Harry G and Stewart, Lindsay B and Brandner-Garrod, Luke and Kristan, Mojca and Sterk, Geert-Jan and van Nuland, Youri M and Manko, Emilia and van Schalkwyk, Donelly A and Zheng, Yang and Leurs, Rob and Dechering, Koen J and Aguiar, Anna Caroline C and Guido, Rafael V C and Pereira, Dhelio B and Tumwebaze, Patrick K and Nosbya, Samuel L and Rosenthal, Philip J and Cooper, Roland A and Palmer, Mike and Parkinson, Tanya and Burrows, Jeremy N and Uhlemann, Anne-Catrin and Birkholtz, Lyn-Marié and Small-Saunders, Jennifer L and Duffy, James and Fidock, David A and Brown, Alan and Gardner, Mark and Baker, David A},
  title = {Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {49},
  doi = {10.1126/sciadv.adq1383}
}
Kostenlos starten →